A major wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' (NYSE:ABT) FreeStyle Libre 3 and Libre 3 Plus glucose monitoring systems. The claim links the products to seven ...

Over the last six months, Abbott Laboratories’s shares have sunk to $116.31, producing a disappointing 11.5% loss - a stark ...

Abbott Laboratories (NYSE:ABT) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February ...

Abbott Laboratories (NYSE:ABT) is included among the Dividend Growth Stocks: 25 Aristocrats. Courtesy of Abbott Labs A Reuters report said Abbott Laboratories (NYSE:ABT) warned that its ...

Abbot⁠t Labor‌atories (NYSE :ABT) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Courtesy of Abbott Labs Abbot⁠t Labor‌atories (NYSE :ABT) has lo‌ng⁠ been a household name ...

An Illinois judge sided with Abbott (NYSE:ABT) in a lawsuit related to alleged data sharing with its continuous glucose ...

Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter on Wednesday and narrowed its fiscal 2025 guidance. The company reported third-quarter sales of $11.37 billion, slightly ...

On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA System to treat patients with atrial fibrillation, or AFib. The company ...

Abbott Laboratories (NYSE: ABT) will release its fiscal fourth-quarter earnings report next Thursday before the opening bell, setting up an intriguing idea for bullish options traders. Ordinarily, ABT ...

Abbott is an innovator and has made plenty of highly successful breakthroughs. That's what it did with its FreeStyle Libre ...

In November 2025, Abbott struck an agreement to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact Sciences develops cancer screening and diagnostic tests. Its ...